Amino acids in the COOH-terminal region of the oxytocin receptor third intracellular domain are important for receptor function

American Journal of Physiology - Endocrinology and Metabolism

Volumn 292, Issue 4, 2007, Pages

  Zhong, Miao ^a   Parish, Bridgette ^b   Murtazina, Dilyara A ^a   Ku, Chun Ying ^a   Sanborn, Barbara M ^a,b  

^a Department of Ecosystem Science and Sustainability   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Extracellular signal regulated protein kinase 1 2; G protein; Phospholipase C; Vasopressin type II receptor

Indexed keywords

ALANINE; MITOGEN ACTIVATED PROTEIN KINASE; OXYTOCIN RECEPTOR; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL;

ALANINE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARGININE; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE DELETION; HUMANS; INTRACELLULAR MEMBRANES; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHATIDYLINOSITOLS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; RECOMBINANT FUSION PROTEINS; VASOPRESSINS;

EID: 34047204825     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00531.2005     Document Type: Article

References (47)

1. Ballesteros JA, Jensen AD, Liapakis G, Rasmussen S, Shi L, Gether U, Javitch JA. Activation of the β2 adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem 276: 29171-29177, 2001.
2. Ballesteros JA, Shi L, Javitch JA. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol Pharmacol 60: 1-19, 2001.
3. Ballesteros JA, Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors. Methods Neurosci 25: 366-428, 1995.
4. Barberis C, Mouillac B, Durroux T. Structural bases of vasopressin/oxytocin receptor function. J Endocrinol 156: 223-229, 1998.
5. Burstein E, Spalding T, Brann M. The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling. J Biol Chem 273: 24322-24327, 1998.
6. Cai K, Klein-Seetharaman J, Altenbach C, Hubbell W, Khorana HG. Probing the dark state tertiary structure in the cytoplasmic domain of rhodopsin: proximities between amino acid deduced from spontaneous disulfide bond formation between cysteine pairs engineered in cytoplasmic loop 1, 3, and 4. Biochemistry 40: 12479-12485, 2001.
7. Fanelli F, Barbier P, Zanchetta D, DeBenedetti PG, Chini B. Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. Mol Pharmacol 56: 214-225, 1999.
8. Farrens DL, Altenbach C, Yang K, Hubbel WL, Khorana HG. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274: 768-770, 1996.
9. Favre N, Fanelli F, Missoten M, Nichols A, Wilson J, di Tiani M, Rommel C, Scheer A. The DRY motif as a molecular switch of the human oxytocin receptor. Biochemistry 44: 9990-10008, 2005.
10. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21: 90-113, 2000.
11. Gimpl G, Klein U, Reilander H, Fahrenholz F. Expression of the human oxytocin receptor in baculovirus-infected insect cells: high-affinity binding is induced by a cholesterol-cyclodextrin complex. Biochemistry 34: 13794-13801, 1995.
12. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81: 629-683, 2001.
13. Greasley P, Fanelli F, Rossier O, Abuin L, Cotecchia S. Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol Pharmacol 61: 1025-1032, 2002.
14. Greasley P, Fanelli F, Scheer A, Abuin L, Nenniger-Tosato M, DeBenedetti P, Cotecchia S. Mutational and computational analysis of the α1b-adrenergic receptor: involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J Biol Chem 276: 46485-46494, 2001.
15. Guzzi F, Zanchetta D, Cassoni P, Guzzi V, Francolini M, Parenti M, Chini B. Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene 21: 1658-1667, 2002.
16. Hamm HE. How activated receptors couple to G proteins. Proc Natl Acad Sci USA 98: 4819-4821, 2001.
17. Hashizume T, Yang W, Clay C, Nett T. Internalization rates of murine and ovine gonadotropin-releasing hormone receptors. Biol Reprod 64: 898-903, 2001.
18. Hawtin S, Howard H, Wheatley M. Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes. Biochem J 354: 465-472, 2001.
19. i. Independent mechanisms for elevating intracellular calcium concentrations from intracellular stores. J Biol Chem 274: 28682-28689, 1999.
20. Hogger P, Shockley M, Lameh J, Sadee W. Activating and inactivating mutations in N- and C-terminal i3 loop junctions of muscarinic acetylcholine Hm1 receptors. J Biol Chem 270: 7405-7410, 1995.
21. Huang P, Visiers I, Weinstein H, and Liu-Chen L. The local environment at the cytoplasmic end of TM6 of the mu opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L630(275)E mutation inactivates the mu opioid receptor and reduces the constitutive activity of its T634(279)K mutant. Biochemistry 41: 11972-11980, 2002.
22. Itoh Y, Cai K, Khorana HG. Mapping of contact sites in complex formation between light-activated rhodopsin and transducin by covalent crosslinking: Use of a chemically preactivated reagent. Proc Natl Acad Sci USA 98: 4883-4887, 2001.
23. Jasper J, Harrell C, O'Brien J, Pettibone D. Characterization of the human oxytocin receptor stably expressed in 293 human embryonic kidney cells. Life Sci 57: 2253-2261, 1995.
24. Kim J, Altenbach C, Kono M, Oprian D, Hubbell W, Khorana HG. Structural origins of constitutive activation in rhodopsin: role of the K296/E113 salt bridge. Proc Natl Acad Sci USA 101: 12508-12513, 2004.
25. Kimura T, Makino Y, Saji F, Takemura M, Inoue T, Kikuchi T, Kubota Y, Azuma C, Nobunaga T, Tokugawa Y. Molecular characterization of a cloned human oxytocin receptor. Eur J Endocrinol 131: 385-390, 1994.
26. Lee N, Geoghagen N, Cheng E, Cline R, Fraser C. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors. Mol Pharmacol 50: 140-148, 1996.
27. Lichtarge O, Bourne HR, Cohen FE. An evolutionary trace method defines binding surfaces common to protein families. J Mol Biol 257: 342-358, 1996.
28. Ohmichi M, Koike K, Nohara A, Kanda Y, Sakamoto Y, Zhang ZX, Hirota K, Miyake A. Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. Endocrinology 136: 2082-2087, 1995.
29. Okamoto T, Nishimoto I. Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. J Biol Chem 267: 8342-8346, 1992.
30. Palczewski K, Kumasaka T, Hori T, Behnke AC, Motoshima H, Fox AB, Trong LI, Teller CD, Okada T, Stenkamp ER, Yamamoto M, Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289: 739-745, 2000.
31. Qian A, Wang W, Sanborn BM. Evidence for the involvement of several intracellular domains in the coupling of oxytocin receptor to G alpha(q/11). Cell Signal 10: 101-105, 1998.
32. Rasmussen S, Jensen A, Liapakis G, Ghanouni P, Javitch JA, Gether U. Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Mol Pharmacol 56: 175-184, 1999.
33. Reversi A, Rimoldi V, Marrocco T, Cassoni P, Bussolati G, Parenti M, Chini B. The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism. J Biol Chem 280: 16311-16318, 2005.
34. Rimoldi V, Reversi A, Taverna E, Rosa P, Francolini M, Cassoni P, Parenti M, Chini B. Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains. Oncogene 22: 6054-6060, 2003.
35. Sanborn BM. Hormones and calcium: mechanisms controlling uterine smooth muscle contractile activity. The Litchfield Lecture. Exp Physiol 86: 223-237, 2001.
36. Schulz A, Bruns K, Henklein P, Krause G, Schubert M, Gudermann T, Wray V, Schultz G, Schoneberg T. Requirement of specific intrahelical interactions for stabilizing the inactive conformation of glycoprotein hormone receptors. J Biol Chem 275: 37860-37869, 2000.
37. Shapiro D, Kristiansen K, Weiner D, Kroeze W, Roth B. Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A that involves the disruption of a strong ionic interaction between helices 3 and 6. J Biol Chem 277: 11441-11449, 2002.
38. Sheikh S, Zvyaga T, Lichtarge O, Sakmar T, Bourne H. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F. Nature 383: 347-350, 1996.
39. Strakova Z, Copland JA, Lolait S, Soloff MS. ERK2 mediates oxytocin-stimulated PGE2 synthesis. Am J Physiol Endocrinol Metab 274: E634-E641, 1998.
40. Ward S, Hamdan F, Bloodworth L, Wess J. Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy. J Biol Chem 277: 2247-2257, 2002.
41. Wess J. Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol Ther 80: 231-264, 1998.
42. Wong S. G protein selectivity is regulated by multiple intracellular regions of GPCRs. Neurosignals 12: 1-12, 2003.
43. Yang M, Wang W, Zhong M, Philippi A, Lichtarge O, Sanborn BM. Lysine 270 in the third intracellular domain of the oxytocin receptor is an important determinant for G alpha(q) coupling specificity. Mol Endocrinol 16: 814-823, 2002.
44. Yin D, Gavi S, Wang H, Malbon C. Probing receptor structure/function with chimeric G-protein-coupled receptors. Mol Pharmacol 65: 1323-1332, 2004.
45. Zhong M, Navratil AM, Clay C, Sanborn BM. Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function. Biochemistry 43: 3490-3498, 2004.
46. Zhong M, Yang M, Sanborn BM. Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbeta-gamma and epidermal growth factor receptor tyrosine kinase activation. Endocrinology 144: 2947-2956, 2003.
47. Zhu X, Gilbert S, Birnbaumer M, Birnbaumer L. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density. Mol Pharmacol 46: 460-469, 1994.